After changing its name from Clawdbot to Moltbot to OpenClaw within days, the viral AI agent faces security questions and a ...

If you are wondering whether Amneal Pharmaceuticals at US$14.11 still offers value after a strong run, you are not alone. This article is here to help you size that up clearly. The stock has seen ...

If you are wondering whether FirstService is starting to look attractive after a weak share price patch, you are not alone. This article focuses squarely on what the current price might mean for value ...